Literature DB >> 12112658

Large-scale determination of SNP allele frequencies in DNA pools using MALDI-TOF mass spectrometry.

Monika Werner1, Michael Sych, Nicole Herbon, Thomas Illig, Inke R König, Matthias Wjst.   

Abstract

One of the major challenges in the near future is the identification of genes that contribute to complex disorders. Large scale association studies that utilize a dense map of single nucleotide polymorphisms (SNPs) have been considered as a valuable tool for this purpose. However, genome-wide screens are limited by costs of genotyping thousands of SNPs in a large number of individuals. Here we present a pooling strategy that enables high-throughput SNP validation and determination of allele frequencies in case and control populations. Quantitative analysis of allele frequencies of SNPs in DNA pools is based on matrix-assisted laser desorption/ionization time of flight (MALDI-TOF) mass spectrometry of primer extension assays. We demonstrate the accuracy and reliability of this approach on pools of eight previously genotyped individuals with an allele frequency representation in the range of 0.1 to 0.9. The accuracy of measured allele frequencies was shown in DNA pools of 142 to 186 individuals using additional markers. Allele frequencies determined from the pooled samples deviate from the real frequencies by about 3%. The described method reduces costs and time and enables genotyping of up to thousands of samples by taking advantage of the high-throughput MALDI-TOF technology. Copyright 2002 Wiley-Liss, Inc.

Mesh:

Substances:

Year:  2002        PMID: 12112658     DOI: 10.1002/humu.10094

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  23 in total

1.  Analysis and accurate quantification of CpG methylation by MALDI mass spectrometry.

Authors:  Jörg Tost; Philipp Schatz; Matthias Schuster; Kurt Berlin; Ivo Glynne Gut
Journal:  Nucleic Acids Res       Date:  2003-05-01       Impact factor: 16.971

2.  High-throughput screening for evidence of association by using mass spectrometry genotyping on DNA pools.

Authors:  Karen L Mohlke; Michael R Erdos; Laura J Scott; Tasha E Fingerlin; Anne U Jackson; Kaisa Silander; Pablo Hollstein; Michael Boehnke; Francis S Collins
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-13       Impact factor: 11.205

3.  DNA analysis by fluorescence quenching detection.

Authors:  Ming Xiao; Pui-Yan Kwok
Journal:  Genome Res       Date:  2003-05       Impact factor: 9.043

Review 4.  MALDI-TOF mass spectrometry: a versatile tool for high-performance DNA analysis.

Authors:  Christian Jurinke; Paul Oeth; Dirk van den Boom
Journal:  Mol Biotechnol       Date:  2004-02       Impact factor: 2.695

5.  Rapid and accurate characterisation of short tandem repeats by MALDI-TOF analysis of endonuclease cleaved RNA transcripts.

Authors:  Doris Seichter; Stefan Krebs; Martin Förster
Journal:  Nucleic Acids Res       Date:  2004-01-20       Impact factor: 16.971

6.  SNP discovery in pooled samples with mismatch repair detection.

Authors:  Hossein Fakhrai-Rad; Jianbiao Zheng; Thomas D Willis; Kee Wong; Kent Suyenaga; Martin Moorhead; Jim Eberle; Yvonne R Thorstenson; Ted Jones; Ronald W Davis; Eugeni Namsaraev; Malek Faham
Journal:  Genome Res       Date:  2004-07       Impact factor: 9.043

7.  Associations between DRDs and schizophrenia in a Korean population: multi-stage association analyses.

Authors:  Kyu Young Lee; Eun-Jeong Joo; Yong Ick Ji; Duk-Hwan Kim; Joo Bae Park; In-Won Chung; Sang Ick Lee; Yeon Ho Joo; Yong Min Ahn; Joo Yun Song; Yong Sik Kim
Journal:  Exp Mol Med       Date:  2011-01-31       Impact factor: 8.718

8.  New adjustment factors and sample size calculation in a DNA-pooling experiment with preferential amplification.

Authors:  Hsin-Chou Yang; Chia-Ching Pan; Richard C Y Lu; Cathy S J Fann
Journal:  Genetics       Date:  2005-01       Impact factor: 4.562

9.  Quantifying mixed populations of drug-resistant human immunodeficiency virus type 1.

Authors:  Michael J Moser; Meta Ruckstuhl; Christine A Larsen; Amanda J Swearingen; Miroslaw Kozlowski; Leda Bassit; Prem L Sharma; Raymond F Schinazi; James R Prudent
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

10.  A novel missense ATP1A2 mutation in a Finnish family with familial hemiplegic migraine type 2.

Authors:  M A Kaunisto; H Harno; K R J Vanmolkot; J J Gargus; G Sun; E Hämäläinen; E Liukkonen; M Kallela; A M J M van den Maagdenberg; R R Frants; M Färkkilä; A Palotie; M Wessman
Journal:  Neurogenetics       Date:  2004-05-07       Impact factor: 2.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.